These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 15980916)

  • 1. Prenatal testing for aneuploidy in New Zealand: time for action.
    Stone P
    N Z Med J; 2005 Jun; 118(1217):U1545. PubMed ID: 15980916
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molecular biology usefulness for rapid diagnosis of Down's syndrome and common aneuploidies].
    Fauret AL; Bilan F; Patri S; Couet D; Marechaud M; Pierre F; Gilbert-Dussardier B; Kitzis A
    Gynecol Obstet Fertil; 2009; 37(7-8):611-9. PubMed ID: 19574080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal screening for Down syndrome.
    Ogle RF; Chitty LS
    Hosp Med; 1998 Aug; 59(8):632-6. PubMed ID: 9829057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antenatal screening for Down syndrome: a smattering of epidemiology].
    Boulvain M; Billieux MH; Irion O
    Rev Med Suisse; 2008 Oct; 4(176):2276-8, 2280. PubMed ID: 19025178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
    Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
    Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prenatal screening for Down syndrome: from sequential to combined estimated risk].
    Jouannic JM; Benifla JL
    Gynecol Obstet Fertil; 2006 Jun; 34(6):467-9. PubMed ID: 16716636
    [No Abstract]   [Full Text] [Related]  

  • 7. Population screening for fetal trisomy 21: easy access to screening should be balanced against a uniform ultrasound protocol.
    Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; de Jonge ET; Ombelet WU; Nijhuis JG
    Prenat Diagn; 2005 Nov; 25(11):984-90. PubMed ID: 16240322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for trisomy 18 by maternal age, fetal nuchal translucency, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
    Kagan KO; Wright D; Maiz N; Pandeva I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Sep; 32(4):488-92. PubMed ID: 18726925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
    Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
    Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stepwise sequential aneuploidy screening in clinical practice.
    Wax JR; Cartin A; Smith D; Smith R; Chard R; Carpenter M; Pinette MG
    J Clin Ultrasound; 2012 Jan; 40(1):26-30. PubMed ID: 22102396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive prenatal screening of fetal Down syndrome by maternal plasma DNA sequencing in twin pregnancies.
    Lau TK; Jiang F; Chan MK; Zhang H; Lo PS; Wang W
    J Matern Fetal Neonatal Med; 2013 Mar; 26(4):434-7. PubMed ID: 23035860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current methods of prenatal screening for Down syndrome and other fetal abnormalities.
    Saller DN; Canick JA
    Clin Obstet Gynecol; 2008 Mar; 51(1):24-36. PubMed ID: 18303497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [FISH technique in aneuplodies prenatal diagnosis].
    Gorduza EV; Onofriescu M; Martiniuc V; Grigore M; Mihălceanu E; Iliev G
    Rev Med Chir Soc Med Nat Iasi; 2007; 111(4):990-5. PubMed ID: 18389793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First trimester screening for Down syndrome in multiple pregnancy.
    Cleary-Goldman J; Berkowitz RL
    Semin Perinatol; 2005 Dec; 29(6):395-400. PubMed ID: 16533653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the current dilemma of Down syndrome screening.
    Rose NC
    Obstet Gynecol; 2006 Jan; 107(1):2-3. PubMed ID: 16394031
    [No Abstract]   [Full Text] [Related]  

  • 16. Three stage contingent screening for Down syndrome.
    Huttly WJ; Morris JK; Bestwick JP; Wald NJ; Murphy K; Pandya PP
    Prenat Diagn; 2006 Dec; 26(12):1183; author reply 1184. PubMed ID: 17115454
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-invasive chromosome test raises new questions in prenatal diagnosis about the significance of ultrasound and questions about new screening strategies.
    Tercanli S; Vial Y; Merz E
    Ultraschall Med; 2013 Oct; 34(5):417-20. PubMed ID: 24127381
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.
    Wald NJ; Barnes IM; Birger R; Huttly W
    Prenat Diagn; 2006 Jun; 26(6):539-44. PubMed ID: 16634123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical practice. Prenatal screening for aneuploidy.
    Driscoll DA; Gross S
    N Engl J Med; 2009 Jun; 360(24):2556-62. PubMed ID: 19516035
    [No Abstract]   [Full Text] [Related]  

  • 20. First trimester Down syndrome screening: public health implications.
    Fuchs KM; Peipert JF
    Semin Perinatol; 2005 Aug; 29(4):267-71. PubMed ID: 16104680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.